Skip to main content

Change location

You are currently on the Global (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
    • Global (English)
  • Home
  • we are bracco
    We are Bracco

    Welcome to a World of contrasts

    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
  • Our Portfolio

    Proven offerings for a proven difference

    • X-ray/CT

      Visit our X-ray/CT area to learn about our services and solutions.

    • MRI

      Visit our MRI area to learn about our services and solutions.

    • Ultrasound

      Visit our Ultrasound area to learn about our services and solutions.

    • Nuclear medicine

      Visit our Nuclear medicine area to learn about our services and solutions.

    • Interventional cardiology

      Visit our Interventional cardiology and cath lab area to learn about our services and solutions.

    • Digital solutions
    • Oncology
    • Cardiology
  • Woman looking into microscope
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
  • Bracco Global Academy
    Education

    Learning, together.

    • Next-Gen Projects
    • Bracco Global Academy
    • Our Partnerships
  • Events
  • Ceriano Laghetto
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
Article
Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires
Diana Bracco riceve la cittadinanza onoraria di Torviscosa
Article
Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.
Fulvio Renoldi Bracco Spin Torviscosa
Page
Sustainability - Staging The health and wellbeing of all is our Purpose. Through continuous innovation we guarantee cutting-edge products and sustainable processes. Our manifesto represents the map of our path: the vision that inspires our every day. From there, everything else follows.
sustainability
Article
Innovation in Healthcare Industry and Diagnostic Imaging Innovation is at the heart of Bracco’s activities. The company invited experts to discuss how artificial intelligence (AI) can help develop medicines faster and improve diagnostic accuracy in a dedicated Innovation Day last September.
No image available
Article
Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.
EUSOMII interview
Article
The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.
Bracco Joined the United Nations Global Compact
Article
ECR2024 Bracco@ECR2024, where education meets innovation to shape the future of medical imaging.
Bracco@ECR2024
Article
How Bracco Reached New Heights in 2023 "Customer support, innovation, and sustainability marked 2023" according to Cosimo De Pinto, Senior Vice President of Sales and Marketing at Bracco Diagnostics Inc., who was interviewed by Editor-in-Chief Melisande Rouger of Diagnostic Imaging Europe straight after RSNA2023.
Cosimo De Pinto, Senior Vice President of Sales and Marketing at Bracco Diagnostics Inc.
Article
Samsung Medison and Bracco Imaging announce a new agreement Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28th to March 3rd.
Samsung Medison (CEO, Mr. Yongkwan Kim) and Bracco Imaging (CEO, Dr. Fulvio Renoldi Bracco)
Article
Which value does Bracco give to education? At ECR2024, Francesca Pelliconi, Strategy & Operations Director, Global Marketing at Bracco Imaging, engaged in a conversation with Guido Gebhardt of Diagnostic Imaging Europe (DIE), the leading pan-European resource for medical imaging news, analysis, and trends. 
Francesca Pelliconi interviewed by Guido Gebhardt at ECR 2024
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Education
  • Events
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182